Tossina botulinica per trattare la spasticità post-ictus. PIANETA SALUTE 2.0

Let's talk about spasticity, a painful and disabling consequence that affects a significant percentage of people who have had a stroke. The biopharmaceutical company IPSEN, in collaboration with patient associations and scientific societies, has launched the website "oltrelaspasticità.it," dedicated to post-stroke spasticity in Italy. This condition is often underdiagnosed and undertreated, but can cause serious disabilities that negatively impact the quality of life of patients and their caregivers. Stroke is a sudden cerebrovascular event that can cause a range of neurological deficits, including loss of motor control, sensory changes, and cognitive problems. It is a leading cause of death and disability globally. Risk factors for stroke include high blood pressure, cholesterol, age, gender, lifestyle factors (such as smoking, obesity, physical inactivity), and the use of drugs such as cocaine and oral contraceptives. Spasticity is a complication that can appear some time after a stroke, affecting the patient's mobility and quality of life. It can cause pain, spasms, and uncontrolled movements. Treatment of spasticity may include rehabilitation therapies, orthopedic surgeries, muscle relaxants, and the use of botulinum toxin to specifically reduce muscle tone. Botulinum toxin has been described as a significant advance in the treatment of post-stroke spasticity. The website "oltrelaspasticità.it" was created to provide verified information on post-stroke spasticity, list specialized centers in Italy, and offer psychological support to patients and their caregivers. It also provides information on patient rights, including financial benefits and disability recognition. Overall, the primary goal is to improve the quality of life of patients with post-stroke spasticity through comprehensive, multidisciplinary management of their condition. Interviews with: Dr. Giovanni Morone, Physiatrist, Neurorehabilitation Unit, Santa Lucia Foundation IRCCS, Rome, and member of the Board of Directors of SIRN, the Italian Society of Neurological Rehabilitation; Prof. Francesco Bono, Head of the Center for Botulinum Toxin Therapy, Neurology Unit, Mater Domini University Hospital, Catanzaro, and National Coordinator of the SIN Italian Botulinum Toxin Network Study Group; Dr. Nicoletta Reale, President of A.L.I.Ce. Italia OdV; Dr. Paola Mazzanti, Medical & Regulatory Affairs Director of IPSEN SpA. #stroke #beyondspasticity #botulinumtoxin ********************* 🔥 Follow us! Magazine: http://www.PianetaSalute.online IG:   / pianetasalute2.0   Twitter:   / pianetasalute   Facebook:   / pianetasalute   And subscribe to our YouTube channel! 00:00 Introduction to Beyond Post-Stroke Spasticity 01:12 The Importance of Stroke as a Global Problem 03:03 Risk Factors and Main Consequences of Stroke 05:06 Spasticity as a Complication of Stroke 08:18 Impact of Spasticity on Quality of Life 11:21 Diagnosis and Treatment of Post-Stroke Spasticity 15:49 Therapeutic Approaches to Improve Mobility 18:13 Focused Treatment with Botulinum Toxin